Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
27 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Acacia Pharma Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Acacia Pharma Ltd. - Product Pipeline Review - 2014', provides an overview of the Acacia Pharma Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Acacia Pharma Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Acacia Pharma Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Acacia Pharma Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Acacia Pharma Ltd.'s pipeline products Reasons to buy - Evaluate Acacia Pharma Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Acacia Pharma Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Acacia Pharma Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Acacia Pharma Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acacia Pharma Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Acacia Pharma Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Acacia Pharma Ltd. Snapshot 5 Acacia Pharma Ltd. Overview 5 Key Information 5 Key Facts 5 Acacia Pharma Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Acacia Pharma Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Acacia Pharma Ltd. - Pipeline Products Glance 11 Acacia Pharma Ltd. - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 Acacia Pharma Ltd. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Acacia Pharma Ltd. - Drug Profiles 13 APD-421 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 (megestrol acetate + formoterol fumarate) 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 APD-403 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 APD-515 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Acacia Pharma Ltd. - Pipeline Analysis 17 Acacia Pharma Ltd. - Pipeline Products by Target 17 Acacia Pharma Ltd. - Pipeline Products by Route of Administration 18 Acacia Pharma Ltd. - Pipeline Products by Molecule Type 19 Acacia Pharma Ltd. - Pipeline Products by Mechanism of Action 20 Acacia Pharma Ltd. - Recent Pipeline Updates 21 Acacia Pharma Ltd. - Dormant Projects 23 Acacia Pharma Ltd. - Discontinued Pipeline Products 24 Discontinued Pipeline Product Profiles 24 APD-405 24 Acacia Pharma Ltd. - Locations And Subsidiaries 25 Head Office 25 Appendix 26 Methodology 26 Coverage 26 Secondary Research 26 Primary Research 26 Expert Panel Validation 26 Contact Us 27 Disclaimer 27
List of Tables Acacia Pharma Ltd., Key Information 5 Acacia Pharma Ltd., Key Facts 5 Acacia Pharma Ltd. - Pipeline by Indication, 2014 7 Acacia Pharma Ltd. - Pipeline by Stage of Development, 2014 8 Acacia Pharma Ltd. - Monotherapy Products in Pipeline, 2014 9 Acacia Pharma Ltd. - Combination Treatment Modalities in Pipeline, 2014 10 Acacia Pharma Ltd. - Phase III, 2014 11 Acacia Pharma Ltd. - Phase II, 2014 12 Acacia Pharma Ltd. - Pipeline by Target, 2014 17 Acacia Pharma Ltd. - Pipeline by Route of Administration, 2014 18 Acacia Pharma Ltd. - Pipeline by Molecule Type, 2014 19 Acacia Pharma Ltd. - Pipeline Products by Mechanism of Action, 2014 20 Acacia Pharma Ltd. - Recent Pipeline Updates, 2014 21 Acacia Pharma Ltd. - Dormant Developmental Projects,2014 23 Acacia Pharma Ltd. - Discontinued Pipeline Products, 2014 24
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.